Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 4641-4650 of 10864

Edit search filters
  1. A Study to Evaluate Platelet Rich Plasma (PRP) for Facial and Hand Skin Rejuvenation

    Jacksonville, FL

  2. Prospective Assessment of Premature Ventricular Contractions Suppression in Cardiomyopathy(PAPS)

    Rochester, MN

  3. Study of IVIg vs. Placebo to Treat Subjects with Stiff-Person Syndrome (SPS) Spectrum Disorders

    Rochester, MN

  4. An Open-label, Phase 2 Basket Study of Neratinib in Patients with Solid Tumors with Somatic Activating HER Mutations

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  5. Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer

    Rochester, MN, Scottsdale/Phoenix, AZ

  6. Selinexor in Advanced Liposarcoma

    Jacksonville, FL, Rochester, MN

  7. A Study of the Safety, Effectiveness and Maximum Tolerated Dose of Oral PQR309 for Patients with Advanced Solid Tumors

  8. Avelumab In Patients With Previously Treated Advanced Stage Classical Hodgkin's Lymphoma (JAVELIN HODGKINS)

    Rochester, MN

  9. CODY: A Study Evaluating The Safety And Efficacy Of QTORIN 3.9% Sirolimus Topical Gel For The Prevention Of Basal Cell Carcinomas (BCCs) In Patients With Gorlin Syndrome

    Scottsdale/Phoenix, AZ, Rochester, MN

  10. Pre-transplant Health Coaching to Improve Patient-Reported Outcomes in Lung Transplant Candidates

    Rochester, MN, Jacksonville, FL

.

Mayo Clinic Footer